Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Gruber-Wackernagel

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Photodermatology, Photoimmunology & Photomedicine|April 8, 2015
Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or functionEleonora Reginato, Alexandra Gruber-Wackernagel, Peter Wolf
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Pathogenic mechanisms of polymorphic light eruptionAlexandra Gruber-Wackernagel, Scott N Byrne, Peter Wolf
Experimental Dermatology|April 7, 2009
New insights into the mechanisms of polymorphic light eruption: resistance to ultraviolet radiation-induced immune suppression as an aetiological factorPeter Wolf, Scott N Byrne, Alexandra Gruber-Wackernagel
Dermatologic Clinics|June 4, 2014
Polymorphous light eruption: clinic aspects and pathogenesisAlexandra Gruber-Wackernagel, Scott N Byrne, Peter Wolf
Photodermatology, Photoimmunology & Photomedicine|September 30, 2018
Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseasesAlexandra Gruber-Wackernagel, Angelika Hofer, Franz Legat, et al.
The American Journal of Dermatopathology|May 6, 2017
Nodular Sclerodermatous Chronic Cutaneous Graft-Versus-Host Disease (GvHD): A New Clinicopathological Variant of Cutaneous Sclerodermatous GvHD Resembling Nodular/Keloidal SclerodermaLucía Prieto-Torres, Francesca Boggio, Alexandra Gruber-Wackernagel, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|September 7, 2012
Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardeningAlexandra Gruber-Wackernagel, Barbara Obermayer-Pietsch, Scott N Byrne, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|December 22, 2015
Correction: Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D(3) that increase upon 311 nm UVB photohardeningAlexandra Gruber-Wackernagel, Barbara Obermayer-Pietsch, Scott N Byrne, et al.
Experimental Dermatology|July 5, 2016
Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference?Peter Wolf, Wolfgang Weger, VijayKumar Patra, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 31, 2008
Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudineAlexandra Gruber-Wackernagel, Michael Scarpatetti, Martin Jochen Gruber, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Photodermatology, Photoimmunology & Photomedicine|April 8, 2015
Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or functionEleonora Reginato, Alexandra Gruber-Wackernagel, Peter Wolf
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Pathogenic mechanisms of polymorphic light eruptionAlexandra Gruber-Wackernagel, Scott N Byrne, Peter Wolf
Experimental Dermatology|April 7, 2009
New insights into the mechanisms of polymorphic light eruption: resistance to ultraviolet radiation-induced immune suppression as an aetiological factorPeter Wolf, Scott N Byrne, Alexandra Gruber-Wackernagel
Dermatologic Clinics|June 4, 2014
Polymorphous light eruption: clinic aspects and pathogenesisAlexandra Gruber-Wackernagel, Scott N Byrne, Peter Wolf
Photodermatology, Photoimmunology & Photomedicine|September 30, 2018
Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseasesAlexandra Gruber-Wackernagel, Angelika Hofer, Franz Legat, et al.
The American Journal of Dermatopathology|May 6, 2017
Nodular Sclerodermatous Chronic Cutaneous Graft-Versus-Host Disease (GvHD): A New Clinicopathological Variant of Cutaneous Sclerodermatous GvHD Resembling Nodular/Keloidal SclerodermaLucía Prieto-Torres, Francesca Boggio, Alexandra Gruber-Wackernagel, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|September 7, 2012
Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardeningAlexandra Gruber-Wackernagel, Barbara Obermayer-Pietsch, Scott N Byrne, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|December 22, 2015
Correction: Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D(3) that increase upon 311 nm UVB photohardeningAlexandra Gruber-Wackernagel, Barbara Obermayer-Pietsch, Scott N Byrne, et al.
Experimental Dermatology|July 5, 2016
Desired response to phototherapy vs photoaggravation in psoriasis: what makes the difference?Peter Wolf, Wolfgang Weger, VijayKumar Patra, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 31, 2008
Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudineAlexandra Gruber-Wackernagel, Michael Scarpatetti, Martin Jochen Gruber, et al.
Pageof 4